Howard Blumstein, MD, urges rheumatologists to recruit patient advocates, visit legislators, attend state society meetings
Generic Colchicine Approved for Gout Prophylaxis
The cost for therapeautic gout treatment may soon go down, thanks to a recent court ruling
How to Engage Congress on Rheumatology Issues without Leaving Home
Ways to connect with Congressional leaders in their home districts
The ACR Advocates for Drug Coverage, Payment Policies to Protect Rheumatology Patients, Practices
Rheumatologists must be adequately compensated for managing patients with complex drug therapies and Medicare beneficiaries need access to biologic treatments
Commentary: Generic Drugs Can Increase Opportunities for Medication Errors
Why dispensing pharmacies should provide color chart of generic drugs they substitute each month
United States’ 114th Congress Starts Its Session
A breakdown of the political makeup of Congress as the ACR, RheumPAC gear up to meet, educate newly elected lawmakers
New Opportunities to Advance Rheumatology Through State Advocacy in 2015
As state legislatures reconvene, the ACR is identifying states, collaborative partners to help pursue legislation
What the Physician Payment Sunshine Act & Open Payments Database Mean in Practice
Revised CMS policy on payments, transfers of value to physicians incorporates exemption for continuing medical education
Congress Can Begin Work to Advance Rheumatology Before New Year
Medicare Advantage plans, specialty tier drug spending, SGR repeal, biomedical research funding issues on lawmakers’ plates
The ACR: Looking Ahead to 2015 and Beyond
Incoming president E. William St.Clair, MD, sets goals, reviews groundwork for the coming year
- « Previous Page
- 1
- …
- 59
- 60
- 61
- 62
- 63
- …
- 85
- Next Page »